3,5-diiodothyropropionic acid has been researched along with 3,3',5-triiodothyropropionic acid in 1 studies
| Studies (3,5-diiodothyropropionic acid) | Trials (3,5-diiodothyropropionic acid) | Recent Studies (post-2010) (3,5-diiodothyropropionic acid) | Studies (3,3',5-triiodothyropropionic acid) | Trials (3,3',5-triiodothyropropionic acid) | Recent Studies (post-2010) (3,3',5-triiodothyropropionic acid) |
|---|---|---|---|---|---|
| 47 | 4 | 12 | 13 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Actis, M; Evison, B; Fujii, N; Inoue, A; Perry, S; Punchihewa, C | 1 |
1 other study(ies) available for 3,5-diiodothyropropionic acid and 3,3',5-triiodothyropropionic acid
| Article | Year |
|---|---|
Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship | 2013 |